ELEPHANTIASIS NOSTRAS VERRUCOSA

This adverse event was reported 8 times

ELEPHANTIASIS NOSTRAS VERRUCOSA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE 1 0.0007
1 JOCK ITCH SPRAY 1 0.0007
2 BELUMOSUDIL 1 0.0003
3 EVEROLIMUS TABLETS 5 0.0003
4 SIPULEUCEL-T 1 0.0002
5 SIROLIMUS 2 0.0001
6 MICONAZOLE NITRATE 1 0.0001
7 EVEROLIMUS 5 0.0001
8 MYCOPHENOLATE MOFETIL 2 0.0000
9 RUXOLITINIB 1 0.0000
See all drugs enriched for association with ELEPHANTIASIS NOSTRAS VERRUCOSA

ELEPHANTIASIS NOSTRAS VERRUCOSA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Autologous Cellular Immunotherapy [EPC] 1 0.0002
1 Kinase Inhibitor [EPC] 6 0.0000
2 Janus Kinase Inhibitor [EPC] 1 0.0000
3 Thiazide Diuretic [EPC] 1 0.0000
4 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
5 Corticosteroid [EPC] 3 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
7 Thalidomide Analog [EPC] 1 0.0000
See all drug classes enriched for association with ELEPHANTIASIS NOSTRAS VERRUCOSA